Segulah pockets €175m on Medstop sale

The exit to pharmaceuticals group Oriola-KD is the first by the Swedish firm’s Fund IV, a 2008 vintage now 70% invested.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this